Biofidelity to present ASPYRE®-Lung data at AACR 2024
/PRNewswire/ -- Biofidelity, a revolutionary genomic technology company dedicated to bringing the benefits of precision medicine to patients around the world,...
Stay updated with breaking news from Late Breaking Abstract. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Biofidelity, a revolutionary genomic technology company dedicated to bringing the benefits of precision medicine to patients around the world,...
(MENAFN - PR Newswire) ASPYRE-Lung addresses critical gaps in NGS-based biomarker testing: Late Breaking Abstract data demonstrate 98% of NGS QC fails can be rescued CAMBRIDGE, England and RESEARCH ... ...
Genomic tech company Biofidelity, which has operations in Cambridge and North Carolina commercialising precision medicine for patients worldwide, has raised $24 million growth capital.
-- The Company will present updated data in a late-breaking poster session for povetacicept in IgA nephropathy patients -- -- The Company will host an investor event the same day concurrently with...
Updated TAILORx follow-up data showing the integration of clinico-pathologic criteria and Recurrence Score® results to refine distant recurrence risk estimates...